Publications
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup
Venkatramani, V,
Reis, IM,
Castle, EP,
Gonzalgo, ML,
Woods, ME,
Svatek, RS,
Weizer, AZ,
Konety, BR,
Tollefson, M,
Krupski, TL,
Smith, ND,
Shabsigh, A,
Barocas, DA,
Quek, ML,
Dash, A,
Kibel, AS,
Pruthi, RS,
Montgomery, JS,
Weight, CJ,
Sharp, DS,
Chang, SS,
Cookson, MS,
Gupta, GN,
Gorbonos, A,
Uchio, EM,
Skinner, E,
Soodana-Prakash, N,
Becerra, MF,
Swain, S,
Kendrick, K,
Smith, JA,
Thompson, IM,
Parekh, DJ,
J Urol, 2020 Mar; DOI:10.1097/JU.0000000000000565 Holmium laser enucleation of the prostate in Jehovah’s Witness patients
Selim, A,
Nottingham, CU,
York, NE,
Dauw, CA,
Borofsky, MS,
Boris, RS,
Lingeman, JE,
Int Urol Nephrol, 2020 Mar; DOI:10.1007/s11255-019-02331-x Generating high resolution digital mammogram from digitized film mammogram with conditional generative adversarial network.
Zhou, Y,
Wei, J,
Helvie, MA,
Chan, HP,
Zhou, C,
Hadjiiski, L,
Lu, Y,
Proceedings of SPIE, 2020 Mar; Comparison of international ovarian tumor analysis simple rules to society of radiologists in ultrasound guidelines for detection of malignancy in adnexal cysts
Patel-Lippmann, KK,
Sadowski, EA,
Robbins, JB,
Paroder, V,
Barroilhet, L,
Maddox, E,
McMahon, T,
Sampene, E,
Wasnik, AP,
Blaty, AD,
Maturen, KE,
AJR Am J Roentgenol, 2020 Mar; DOI:10.2214/AJR.18.20630 Proteogenomic Characterization of Endometrial Carcinoma
Dou, Y,
Kawaler, EA,
Cui Zhou, D,
Gritsenko, MA,
Huang, C,
Blumenberg, L,
Karpova, A,
Petyuk, VA,
Savage, SR,
Satpathy, S,
Liu, W,
Wu, Y,
Tsai, C-F,
Wen, B,
Li, Z,
Cao, S,
Moon, J,
Shi, Z,
Cornwell, M,
Wyczalkowski, MA,
Chu, RK,
Vasaikar, S,
Zhou, H,
Gao, Q,
Moore, RJ,
Li, K,
Sethuraman, S,
Monroe, ME,
Zhao, R,
Heiman, D,
Krug, K,
Clauser, K,
Kothadia, R,
Maruvka, Y,
Pico, AR,
Oliphant, AE,
Hoskins, EL,
Pugh, SL,
Beecroft, SJI,
Adams, DW,
Jarman, JC,
Kong, A,
Chang, H-Y,
Reva, B,
Liao, Y,
Rykunov, D,
Colaprico, A,
Chen, XS,
Czekański, A,
Jędryka, M,
Matkowski, R,
Wiznerowicz, M,
Hiltke, T,
Boja, E,
Kinsinger, CR,
Mesri, M,
Robles, AI,
Rodriguez, H,
Mutch, D,
Fuh, K,
Ellis, MJ,
DeLair, D,
Thiagarajan, M,
Mani, DR,
Getz, G,
Noble, M,
Nesvizhskii, AI,
Wang, P,
Anderson, ML,
Levine, DA,
Smith, RD,
Payne, SH,
Ruggles, KV,
Rodland, KD,
Ding, L,
Zhang, B,
Liu, T,
Fenyö, D,
Clinical Proteomic Tumor Analysis Consortium, Array,
Cell, 2020 Feb; DOI:10.1016/j.cell.2020.01.026 Rucaparib for recurrent, locally advanced, or metastatic urothelial carcinoma (mUC): Results from ATLAS, a phase II open-label trial.
Grivas, P,
Loriot, Y,
Feyerabend, S,
Morales-Barrera, R,
Teo, MY,
Vogelzang, NJ,
Grande, E,
Zakharia, Y,
Adra, N,
Alva, AS,
Necchi, A,
Gupta, S,
Josephs, DH,
Rodriguez-Vida, A,
Srinivas, S,
Wride, K,
Thomas, D,
Dusek, R,
Nepert, DL,
Chowdhury, S,
Journal of Clinical Oncology, 2020 Feb; DOI:10.1200/jco.2020.38.6_suppl.440 Financial hardship among Medicare beneficiaries prescribed oral targeted therapies for advanced prostate cancer.
Caram, MV,
Oerline, M,
Dusetzina, S,
Modi, PK,
Herrel, LA,
Skolarus, TA,
Hollenbeck, BK,
Shahinian, VB,
Journal of Clinical Oncology, 2020 Feb; DOI:10.1200/jco.2020.38.6_suppl.68 Using bioinformatic tools to examine similarities between human PDL-1 protein and common tobacco (Nicotiana tabacum).
Dib, EG,
Hill, N,
Wollard, J,
Yoo, JW,
Dib, JE,
Ganguly, A,
Cho, C,
Journal of Clinical Oncology, 2020 Feb; DOI:10.1200/jco.2020.38.5_suppl.70 Polypoidal giant cancer cells in metastatic castration-resistant prostate cancer: observations from the Michigan Legacy Tissue Program
Mannan, R,
Wang, X,
Bawa, PS,
Spratt, DE,
Wilson, A,
Jentzen, J,
Chinnaiyan, AM,
Reichert, ZR,
Mehra, R,
Med Oncol, 2020 Feb; DOI:10.1007/s12032-020-1341-6 Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
Wierzbicki, K,
Ravi, K,
Franson, A,
Bruzek, A,
Cantor, E,
Harris, M,
Homan, MJ,
Marini, BL,
Kawakibi, AR,
Ravindran, R,
Teodoro, R,
Yadav, VN,
Koschmann, C,
Curr Oncol Rep, 2020 Feb; DOI:10.1007/s11912-020-0877-0 Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer
Overman, M,
Javle, M,
Davis, RE,
Vats, P,
Kumar-Sinha, C,
Xiao, L,
Mettu, NB,
Parra, ER,
Benson, AB,
Lopez, CD,
Munugalavadla, V,
Patel, P,
Tao, L,
Neelapu, S,
Maitra, A,
J Immunother Cancer, 2020 Feb; DOI:10.1136/jitc-2020-000587 Quality Measures in Postmastectomy Breast Reconstruction: Identifying Metrics to Improve Care
Nasser, JS,
Chung, WHJ,
Gudal, RA,
Kotsis, SV,
Momoh, AO,
Chung, KC,
Plast Reconstr Surg Glob Open, 2020 Feb; DOI:10.1097/GOX.0000000000002630 Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine
Peitzsch, M,
Butch, ER,
Lovorn, E,
Mangelis, A,
Furman, WL,
Santana, VM,
Hero, B,
Berthold, F,
Shulkin, BL,
Huebner, A,
Eisenhofer, G,
Pediatr Blood Cancer, 2020 Feb; DOI:10.1002/pbc.28081 Targeting the MET receptor tyrosine kinase as a strategy for radiosensitization in locoregionally advanced head and neck squamous cell carcinoma
Nisa, L,
Francica, P,
Giger, R,
Medo, M,
Elicin, O,
Friese-Hamim, M,
Wilm, C,
Stroh, C,
Bojaxhiu, B,
Quintin, A,
Caversaccio, MD,
Dettmer, MS,
Buchwalder, M,
Brodie, TM,
Aebersold, DM,
Zimmer, Y,
Carey, TE,
Medová, M,
Mol Cancer Ther, 2020 Feb; DOI:10.1158/1535-7163.MCT-18-1274 Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier
Taylor, AS,
Morgan, TM,
Wallington, DG,
Chinnaiyan, AM,
Spratt, DE,
Mehra, R,
Prostate, 2020 Feb; DOI:10.1002/pros.23926 Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence
Dong, D-H,
Zhang, X-F,
Lopez-Aguiar, AG,
Poultsides, G,
Makris, E,
Rocha, F,
Kanji, Z,
Weber, S,
Fisher, A,
Fields, R,
Krasnick, BA,
Idrees, K,
Smith, PM,
Cho, C,
Beems, M,
Dillhoff, M,
Maithel, SK,
Pawlik, TM,
HPB (Oxford), 2020 Feb; DOI:10.1016/j.hpb.2019.05.020 Outcomes in black and white patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors: Insights from two large cohorts
Bossé, D,
Xie, W,
Lin, X,
Simantov, R,
Lalani, A-KA,
Graham, J,
Wells, JC,
Donskov, F,
Rini, B,
Beuselinck, B,
Alva, A,
Hansen, A,
Wood, L,
Soulières, D,
Kollmannsberger, C,
Patenaude, F,
Heng, DYC,
Choueiri, TK,
McKay, RR,
JCO Glob Oncol, 2020 Feb; DOI:10.1200/JGO.19.00380 Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy
Heft Neal, ME,
Brennan, J,
Brenner, JC,
Shuman, AG,
Chinn, SB,
Stucken, CL,
Malloy, KM,
Moyer, JS,
Casper, KA,
McLean, SA,
Prince, MEP,
Bradford, CR,
Wolf, GT,
Chepeha, DB,
Rosko, AJ,
Spector, ME,
Ann Surg Oncol, 2020 Feb; DOI:10.1245/s10434-019-07841-7 Mutations Predictve of Hyperactive Ras Signaling Correlate With Inferior Survival Across High-Risk Pediatric Axute Leukemia
Ney, GM,
Anderson, B,
Bender, J,
Kumar-Sinha, C,
Wu, Y-M,
Vats, P,
Cieslik, M,
Robinson, DR,
Li, Q,
Chinnaiyan, AM,
Mody, R,
Transl Pediatr, 2020 Feb; DOI:10.21037/tp.2019.12.03 The Johns Hopkins Primary Care for Cancer Survivor Clinic: lessons learned in our first 4 years
Choi, Y,
Radhakrishnan, A,
Mahabare, D,
Patole, S,
Dy, SM,
Pollack, CE,
Berger, ZD,
Peairs, KS,
J Cancer Surviv, 2020 Feb; DOI:10.1007/s11764-019-00816-3 Integrating Subgroups with Mixed-type Endpoints in Early Phase Oncology Trials
Zhao, L,
Koschmann, C,
Stat Methods Med Res, 2020 Feb; DOI:10.1177/0962280219840050 Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment
Kregel, S,
Wang, C,
Han, X,
Xiao, L,
Fernandez-Salas, E,
Bawa, P,
McCollum, BL,
Wilder-Romans, K,
Apel, IJ,
Cao, X,
Speers, C,
Wang, S,
Chinnaiyan, AM,
Neoplasia, 2020 Feb; DOI:10.1016/j.neo.2019.12.003 Prognostic factors in laryngeal squamous cell carcinoma
Bradford, CR,
Ferlito, A,
Devaney, KO,
Mäkitie, AA,
Rinaldo, A,
Laryngoscope Investig Otolaryngol, 2020 Feb; DOI:10.1002/lio2.353 Patterns of stereotactic body radiation therapy: The influence of lung cancer treatment on prostate cancer treatment
Jacobs, BL,
Yabes, JG,
Lopa, SH,
Heron, DE,
Chang, C-CH,
Bekelman, JE,
Nelson, JB,
Bynum, JPW,
Barnato, AE,
Kahn, JM,
Urol Oncol, 2020 Feb; DOI:10.1016/j.urolonc.2019.09.031 Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.
Sangtani, A,
Wang, C,
Weaver, A,
Hoppman, NL,
Kerr, SE,
Abyzov, A,
Shridhar, V,
Staub, J,
Kocher, J-PA,
Voss, JS,
Podratz, KC,
Wentzensen, N,
Kisiel, JB,
Sherman, ME,
Bakkum-Gamez, JN,
Gynecol Oncol, 2020 Feb; DOI:10.1016/j.ygyno.2019.11.028 